Novel BIochemical Markers for Predicting Type 2 NEurological Complications of Surgical Coronary Revascularization (BINER)
NCT ID: NCT03493256
Last Updated: 2020-02-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
100 participants
OBSERVATIONAL
2018-04-01
2019-03-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Vascular Events In Surgery patIents cOhort evaluatioN - Cardiac Surgery
NCT01842568
Bilateral Surgical Resection of Carotid Bodies in Patients With Systolic Heart Failure
NCT01782677
Neuroinflammation/Oxidative Stress/Cardiac Surgery
NCT06391866
Diagnostic and Prognostic Value of Cardiac Biomarkers for Early Coronary Bypass Occlusion in Patients Undergoing Coronary Revascularization
NCT04595630
Prognostic Value of New Cardiac Biomarkers in Elderly Patients Undergoing Cardiac Surgery
NCT00416299
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
type 2 neurological complications present
The group of patients diagnosed with postoperative cognitive dysfunction (POCD) or postoperative delirium (POD), or both concurrently.
exposure to type 2 neurological complications
exposure to postoperative cognitive dysfunction (POCD) or postoperative delirium (POD), or both concurrently.
type 2 neurological complications absent
The group of patients without neurological complications.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
exposure to type 2 neurological complications
exposure to postoperative cognitive dysfunction (POCD) or postoperative delirium (POD), or both concurrently.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* alcohol or drug abuse
* preoperative left ventricular ejection fraction of less than 30%
* extracranial carotid artery stenosis of more than 70%
* scoring below age- and education-adjusted cut-off values in Mini-Mental State Examination (MMSE)
* scoring over seven points on the subscales of the Hospital Anxiety and Depression Scale (HADS)
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Collegium Medicum w Bydgoszczy
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Krzysztof Szwed
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Krzysztof Szwed, Dr
Role: PRINCIPAL_INVESTIGATOR
Department of Clinical Neuropsychology, Nicolaus Copernicus University, Collegium Medicum.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Cardiac Surgery, Dr Antoni Jurasz Memorial University Hospital
Bydgoszcz, Kuyavian-Pomeranian Voivodeship, Poland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KB 776/2017
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.